| 1. | Inhibitory effect of atorvastatin on cardiac hypertrophy and extracellular matrix remodeling in rats
阿托伐他汀对心肌肥厚大鼠细胞外基质重塑的抑制作用 |
| 2. | Treatment with atorvastatin increased the risk of brain hemorrhage by 68 percent , the report indicates
报告指出，阿托伐他汀治疗能增加68的脑出血的风险。 |
| 3. | However , in an unplanned analysis , atorvastatin seemed to slightly increase the risk of brain hemorrhage
尽管如此，在一个不是计划中的分析中却发现，阿托伐他汀似乎可以轻微的增加脑出血的危险性。 |
| 4. | The effects of atorvastatin in left ventricular remodeling and dysfunction of rats with chronic heart failure and possible mechanisms
阿托伐他汀对慢性心力衰竭大鼠左室重构和功能的影响及可能的机制 |
| 5. | However , the researchers " found no evidence that systemic atorvastatin administration produced any significant effect on bone mass or markers .
但是研究者们发现：系统使用阿托伐他汀对骨量或骨的标记物没有显著影响。 |
| 6. | Concentration - dependent effects of atorvastatin calcium on the expression of e - selectin and intercellular adhesion molecule - 1 in cultured human umbilical vein endothelial cells
选择素和细胞间黏附分子1表达的浓度依赖性 |
| 7. | A 65 - year - old woman with primary hypercholesterolaemia developed hepatitis with characteristics of autoimmune hepatitis while receiving atorvastatin
1例65岁妇女因原发性高胆固醇血症接受阿伐他汀治疗，而并发以自身免疫性肝炎为特征的肝损害。 |
| 8. | New york ( reuters health ) jan 08 - atorvastatin , at doses that lower lipid levels , appears to have no effect on bone mineral density or bone metabolism in postmenopausal women , according to researchers
纽约（路透社健康新闻） 1月8日研究者们声称：阿托伐他汀，在它能降低血脂水平的剂量，对于绝经后妇女的骨密度或骨代谢没有影响。 |
| 9. | The main finding of sparcl , he said , was that atorvastatin reduced the risk of stroke by 16 percent in patients who recently had a stroke or tia , a condition in which blood flow to a portion of the brain is temporarily reduced
他说， sparcl研究最大的发现是：阿托伐他汀能降低16在最近有卒中和短暂性缺血（就是一部分的脑血流暂时性的减少的情况）发作经历的患者的再次卒中的危险。 |
| 10. | Statin can lower the blood lipid ( cholesterol ) level . however , it possesses beneficial effect other than lipid - lowering . in a double blind , randomized , controlled study 112 patients with ischaemic heart disease were treated with either oral atorvastatin 10mg daily or atorvastatin 80mg daily for 6 months
一百一十二位冠心病患者参与一项随机双盲对照研究，连续六个月接受每日服用十毫克或八十毫克的阿托伐他汀（胆固清）治疗。 |
